Regenxbio (RGNX) Asset Utilization Ratio (2015 - 2026)

Regenxbio's Asset Utilization Ratio history runs 11 years deep, the most recent figure standing at 0.34 for Q4 2025.

• In Q4 2025, Asset Utilization Ratio rose 101.51% year-over-year to 0.34; the TTM figure through Dec 2025 stood at 0.34 (up 101.51% YoY), while the FY2025 annual figure was 0.34, up 112.21% from the prior year.
• Asset Utilization Ratio for Q4 2025 stood at 0.34, up from 0.29 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.52 in Q3 2022, with the low at 0.11 in Q3 2021.
• The 5-year median for Asset Utilization Ratio is 0.18 (2024), against an average of 0.25.
• Peak annual rise in Asset Utilization Ratio reached 359.18% in 2022, while the deepest fall reached 73.28% in 2022.
• Regenxbio's Asset Utilization Ratio stood at 0.49 in 2021, then slumped by 73.28% to 0.13 in 2022, then climbed by 13.81% to 0.15 in 2023, then advanced by 12.22% to 0.17 in 2024, then jumped by 101.51% to 0.34 in 2025.
• Business Quant data shows RGNX's Asset Utilization Ratio at 0.34 in Q4 2025, 0.29 in Q3 2025, and 0.29 in Q2 2025.